Purdue Pharma Pleads Guilty

Purdue Pharma has pleaded guilty to criminal charges stemming from their role in the opioid crisis.

The Oxycontin manufacturer, Purdue Pharma, has been embattled by state, city, and federal officials for years. Lawsuits have revealed the extent of their wrongdoing, from basically bribing doctors to nonchalance about overdose deaths. Finally, Purdue Pharma is facing the music, giving up eight billion dollars to be split among plaintiffs. The business itself will be given to federal authorities and operate for “the public good.”

The Charges Against Purdue

The federal government pursued criminal charges that were settled through a monetary agreement of 8 billion dollars, including the business’s surrender. While some individual doctors and salespeople (usually middlemen) got reduced charges for testifying, no individuals from the company have been charged as criminals, to the chagrin of many plaintiffs.

The plea deal does not …

Continue Reading

Opioid Victims, Families Can Begin Suing Purdue Pharma

A federal judge has decided that victims of the opioid epidemic have the right to sue Purdue Pharma for damages, but all claims must be filed by June 30, 2020. This is when the company will begin its bankruptcy proceedings.

Purdue has also reached a settlement with a portion of some states and local governments. Although the settlement amount has not been disclosed, it’s been reported that it could be worth more than $10 billion. The presiding Judge, Robert Drain, says it’s important to note that an official amount for settlement has not yet been reached.

What is Purdue Settling For?

Purdue Pharma has faced hundreds of lawsuits accusing them of creating the opioid epidemic that has killed tens of thousands of Americans in the past several years. They are accused of using coercive marketing tactics with doctors, even though …

Continue Reading

U.S. Justice Department Joins Suboxone Lawsuit

The U.S. Justice Department has joined a lawsuit alongside several whistleblowers that alleges that the companies marketed off-label and higher dosages than approved, as well as other deception. Several ex-workers are in the process of suing on behalf of the government, as whistleblower laws allow. It appears the government is now up to speed on the wrongs listed in lawsuits against Indivior Plc. and Reckitt Benckiser Group PLC, both involved in marketing the opioid addiction treatment Suboxone.

What is the Lawsuit About?

One of the complaints unsealed on Aug. 2 was filed by former Reckitt employee Ann Marie Williams, claiming that the companies marketed unapproved dosages and uses of Suboxone and Subutex. Williams Reckitt made misleading claims to the U.S. Food and Drug Administration to obtain approval for a dissolvable film version of Suboxone.

The lawsuits were filed under the …

Continue Reading

Purdue Pharma Says It Will Cease Marketing OxyContin

Purdue Pharma, one of the largest manufacturers of Oxycontin in America, has vowed to stop marketing the opioid to doctors. Oxycontin is an opioid medication that has been on the market for over 20 years and is viewed by many addiction and law enforcement professionals to be the catalyst for America’s current opioid addiction crisis. It’s a common drug of abuse and is often responsible for overdoses.

Purdue released a statement saying that it would no longer send sales representatives to market the opioid painkiller at doctor’s offices and that the Medical Affairs office will now handle all Oxycontin orders and queries.

Many people involved in the addiction industry, the medical community and other public heatlh experts say it’s too little, too late.

Purdue has long marketed Oxycontin as effective and safe for use, dropping off samples at the offices …

Continue Reading